Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Active immunization against varicella infection
Age: greater than 12 years
Dose: Subcutaneous – 0.5 ml
Frequency: 2 doses
Note: 2nd dose to be given at least 4 weeks later after the 1st dose.
Indication: Postexposure vaccination
Age: greater than 12 years
Dose: Subcutaneous – 0.5 ml
Frequency: Single dose
Note: Given within 3-5 days post-exposure. 2nd dose to be given 4 weeks after the 1st dose.

Child Dose

Clinical InformationAdministration Information
Indication: Active immunisation against varicella infection
Age: Child: greater than 12 years
Dose: Subcutaneous – 0.5 ml
Frequency: 2 doses
Note: 2nd dose to be given at least 4 weeks later after the 1st dose
Indication: Active immunisation against varicella infection
Age: Child: 1-12 years
Dose: Subcutaneous – 0.5 ml
Frequency: single dose
Note: If necessary, a 2nd dose is to be given at least 3 months later
Administration
  • Give subcutaneously
  • Store in refrigerator
Side Effect

Drug Interaction

Drug NameRisk Factors
Salicylates
Avoid use for 6 wk after vaccination to reduce risk of Reye's syndrome
Antiviral agents active against herpes virus (e.g. aciclovir, valaciclovir)
Decreased efficacy of vaccine

Disease Interaction

Disease NameRisk Factors
Primary immunodeficiency
Vaccine may be dangerous
Active febrile infection
Postpone vaccination

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 2-8° C. Do not freeze. Protect from light. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.